Showing results (181-190 of 197) with videos related to
Sort By:
Pageof 20
Nature Communications|March 5, 2015
Analysis of intestinal microbiota in hybrid house mice reveals evolutionary divergence in a vertebrate hologenomeJun Wang, Shirin Kalyan, Natalie Steck, et al.Frontiers in Immunology|February 23, 2026
Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from in vitro assaysMiriam Kelm, Nourhan Nasr, Sonja Bendig, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2017
The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal FragmentsJanna Schneppenheim, Ann-Christine Loock, Susann Hüttl, et al.Journal of Leukocyte Biology|January 23, 2020
Pitfalls in the characterization of circulating and tissue-resident human γδ T cellsNicola Beucke, Daniela Wesch, Hans-Heinrich Oberg, et al.Biological Chemistry|October 30, 2021
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigenChristian Kellner, Sebastian Lutz, Hans-Heinrich Oberg, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 19, 2016
Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patientsHans-Heinrich Oberg, Evelin Grage-Griebenow, Sabine Adam-Klages, et al.Nature Immunology|November 14, 2018
The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsivenessDaisy Melandri, Iva Zlatareva, Raphaël A G Chaleil, et al.Blood|August 23, 2017
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapyInga Nagel, Marius Bartels, Johannes Duell, et al.Frontiers in Immunology|December 19, 2022
Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIVClara Bessen, Carlos Plaza-Sirvent, Agit Simsek, et al.Cell Reports|May 27, 2014
The CD3 conformational change in the γδ T cell receptor is not triggered by antigens but can be enforced to enhance tumor killingElaine P Dopfer, Frederike A Hartl, Hans-Heinrich Oberg, et al.Pageof 20